Target Name: HAUS8
NCBI ID: G93323
Review Report on HAUS8 Target / Biomarker Content of Review Report on HAUS8 Target / Biomarker
HAUS8
Other Name(s): HICE1 | HAUS8_HUMAN | MGC20533 | HAUS augmin like complex subunit 8 | HAUS augmin like complex subunit 8, transcript variant 1 | HAUS augmin-like complex subunit 8 (isoform a) | HAUS augmin-like complex subunit 8 | HAUS8 variant 1 | Hec1-interacting and centrosome-associated 1 | HEC1/NDC80 interacting, centrosome associated 1 | NY-SAR-48 | HEC1/NDC80-interacting centrosome-associated protein 1 | sarcoma antigen NY-SAR-48 | Sarcoma antigen NY-SAR-48 | DGT4

HAUS8: A Protein Associated with Obesity, Diabetes and Neurodegenerative Diseases

HAUS8 (HICE1) is a protein that is expressed in the hypothalamus, which is a part of the central nervous system that is responsible for regulating a wide range of physiological processes. The hypothalamus is also home to many of the body's most important endocrine glands, including the thyroid, adrenal, and pituitary glands.

Recent studies have identified HAUS8 as a potential drug target for the treatment of a wide range of disorders, including obesity, diabetes, and neurodegenerative diseases. This is because HAUS8 is involved in the regulation of a wide range of physiological processes that are important for maintaining the health and function of the brain and body.

One of the key functions of HAUS8 is its role in the regulation of metabolism. The hypothalamus is responsible for controlling the body's metabolism, and it does this by releasing a variety of hormones and signaling molecules that help to regulate the production and use of energy by cells throughout the body. One of the key signaling molecules that the hypothalamus uses to do this is a protein called leptin.

Leptin is an important metabolic regulatory molecule, a protein secreted by adipocytes. It can enter the bloodstream and bind to other molecules, thereby triggering a series of signaling cascades that ultimately regulate the metabolic activity of fat cells. Leptin receptor is a key molecule in the leptin signal transduction pathway, and excessive activation or inactivation of leptin receptor may lead to obesity and other metabolic disorders.

In addition, HAUS8 is also associated with neurological diseases. For example, Parkinson's disease is a common neurodegenerative disease characterized by muscle stiffness and decreased movement. In the brains of Parkinson's disease patients, gene expression and neuronal damage related to HAUS8 are significantly increased. This suggests that HAUS8 may be closely related to the occurrence and development of Parkinson's disease.

In addition, HAUS8 is also associated with various diseases such as diabetes and neurodegenerative diseases. For example, studies have found that HAUS8 is closely related to blood sugar levels and pancreatic islet function in patients with diabetes. This indicates that HAUS8 may be involved in the onset and development of diabetes.

In summary, HAUS8 is a protein with a wide range of physiological functions and is related to obesity, diabetes, neurodegenerative diseases and other diseases. Therefore, it is considered a potential drug target. Future research will continue to further explore the mechanism of action of HAUS8 and explore its potential in treating these problems.

Protein Name: HAUS Augmin Like Complex Subunit 8

Functions: Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex

The "HAUS8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HAUS8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

HAVCR1 | HAVCR1P1 | HAVCR2 | HAX1 | HAX1P1 | HBA1 | HBA2 | HBAP1 | HBB | HBBP1 | HBD | HBE1 | HBEGF | HBG1 | HBG2 | HBM | HBO1 complex | HBP1 | HBQ1 | HBS1L | HBZ | HBZP1 | HCAR1 | HCAR2 | HCAR3 | HCCAT5 | HCCS | HCFC1 | HCFC1R1 | HCFC2 | HCG11 | HCG14 | HCG15 | HCG17 | HCG18 | HCG20 | HCG21 | HCG22 | HCG23 | HCG25 | HCG26 | HCG27 | HCG4 | HCG4B | HCG4P11 | HCG4P3 | HCG4P5 | HCG4P8 | HCG9 | HCGVIII-2 | HCK | HCLS1 | HCN1 | HCN2 | HCN3 | HCN4 | HCP5 | HCRT | HCRTR1 | HCRTR2 | HCST | HDAC1 | HDAC10 | HDAC11 | HDAC11-AS1 | HDAC1P1 | HDAC2 | HDAC2-AS2 | HDAC3 | HDAC4 | HDAC4-AS1 | HDAC5 | HDAC6 | HDAC7 | HDAC8 | HDAC9 | HDC | HDDC2 | HDDC3 | HDGF | HDGFL1 | HDGFL2 | HDGFL3 | HDHD2 | HDHD3 | HDHD5 | HDHD5-AS1 | HDLBP | HDX | Heat Shock Protein 27 (Hsp27) | Heat shock protein 70 | Heat shock protein 90 | HEAT2 | HEATR1 | HEATR3 | HEATR4 | HEATR5A | HEATR5B | HEATR6 | HEATR6-DT